Depression and Anxiety Trial, Recruiting NCT07415941 Sponsor: Florida State University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07415941
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 50 and 85 years old
  • People whose memory and thinking are assessed as being within a normal range on a standard cognitive test
  • People who have been experiencing moderate low back pain daily or almost every day for at least the past three months (rated 3 or more out of 10 on a pain scale)
  • People who have been experiencing mild to moderate depressive symptoms, as measured by a standard depression questionnaire (PHQ-9 score between 5 and 19)
  • People who are able to speak and read English
  • People who do not plan to change any pain medications during the trial period

Who may not be able to join:

  • People with a serious underlying illness, such as cancer
  • People with certain other mental health conditions involving psychosis
  • People assessed as having an elevated risk of suicide based on a standard safety rating scale
  • People whose physical limitations would prevent them from taking part in meditation practice
  • People who have previously participated in a meditation program
  • People with certain heart or cardiovascular conditions, a recent ear injury, metal implants in or above the neck area, or other conditions that may make a specific type of ear-based nerve stimulation used in this trial unsuitable (confirm with trial site for full details)
  • People who do not have access to the internet

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 18506450657

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Florida State University
Registry
ClinicalTrials.gov
Start date
30 January 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in pain intensity and interference; Change in depressive symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov